Perspectives on Payment Policies for Gene Therapies

Tuesday, November 5

This program will address the status of legislative and regulatory solutions to the primary challenges in paying for gene therapies for different payer types (Medicaid, Medicare, and commercial payers), as well as the current state of Medicaid reimbursement policies for these therapies.

Programming schedule is as follows:

  • Enabling alternative payment models and other novel solutions
  • Landscape and challenges in Medicaid reimbursement of gene therapies
  • Medicare issues: Coverage, reimbursement, and NTAP reform


  • Member: $200
  • Non-Member: $250

Register today for the Tuesday, November 5 session, Global Regulatory Issues in Gene Therapy Development, or all of the ASGCT 2019 Policy Summit.

ASGCT Policy Summit
November 4 – 6 | Washington D.C.